SKI Market

A+| A| A-|

Indian Indices

Sensex

75,674.75 276.03
( 0.37%)

Global Indices

Nasdaq

50,087.63 373.42
(0.75%)

Dow Jones

7,522.46 57.21
(0.77%)

Hang Seng

62,791.91 -480.20
(-0.76%)

Nikkei 225

10,362.65 37.30
(0.36%)

Forex

USD-INR

95.64 0.03
(0.04%)

EUR-INR

112.06 -0.23
(-0.21%)

GBP-INR

129.33 -0.17
(-0.13%)

JPY-INR

0.61 0.00
(-0.10%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

43.02

849.69

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.21

Back

Monolithisch India standalone net profit rises 25.89% in the December 2025 quarter

Jan 27,2026

Net profit of Monolithisch India rose 25.89% to Rs 4.96 crore in the quarter ended December 2025 as against Rs 3.94 crore during the previous quarter ended December 2024. Sales rose 17.49% to Rs 30.77 crore in the quarter ended December 2025 as against Rs 26.19 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	30.77	26.19	17
OPM %	22.85	22.72	-
PBDT	7.35	5.89	25
PBT	6.68	5.49	22
NP	4.96	3.94	26

75,674.75 276.03 ( 0.37%)

50,087.63 373.42 (0.75%)

7,522.46 57.21 (0.77%)

62,791.91 -480.20 (-0.76%)

10,362.65 37.30 (0.36%)

95.64 0.03 (0.04%)

112.06 -0.23 (-0.21%)

129.33 -0.17 (-0.13%)

0.61 0.00 (-0.10%)